See more : Janux Therapeutics, Inc. (JANX) Income Statement Analysis – Financial Results
Complete financial analysis of Onconova Therapeutics Inc. Warrants (ONTXW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Onconova Therapeutics Inc. Warrants, a leading company in the industry within the sector.
You may be interested
- Torrent Pharmaceuticals Limited (TORNTPHARM.NS) Income Statement Analysis – Financial Results
- Fenbi Ltd. (2469.HK) Income Statement Analysis – Financial Results
- Mazda Motor Corporation (MZDAY) Income Statement Analysis – Financial Results
- Leggett & Platt, Incorporated (0JTT.L) Income Statement Analysis – Financial Results
- The GEO Group, Inc. (GEO) Income Statement Analysis – Financial Results
Onconova Therapeutics Inc. Warrants (ONTXW)
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 231.00K | 2.18M | 1.23M | 787.00K | 5.55M | 11.46M | 800.00K | 4.75M | 46.19M | 1.49M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 231.00K | 2.18M | 1.23M | 787.00K | 5.55M | 11.46M | 800.00K | 4.75M | 46.19M | 1.49M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 16.90M | 15.54M | 16.92M | 19.12M | 20.07M | 25.90M | 49.43M | 50.18M | 52.76M | 22.62M |
General & Administrative | 8.33M | 8.35M | 7.59M | 7.41M | 0.00 | 9.53M | 15.12M | 16.79M | 0.00 | 6.44M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 8.33M | 8.35M | 7.59M | 7.41M | 0.00 | 9.53M | 15.12M | 16.79M | 0.00 | 6.44M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 9.18M | 0.00 | 0.00 | 0.00 | 15.71M | 0.00 |
Operating Expenses | 25.22M | 23.88M | 24.51M | 26.52M | 29.25M | 35.43M | 64.54M | 66.98M | 68.47M | 29.06M |
Cost & Expenses | 25.22M | 23.88M | 24.51M | 26.52M | 29.25M | 35.43M | 64.54M | 66.98M | 68.47M | 29.06M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00K | 4.00K | 8.61M | 19.00K |
Depreciation & Amortization | 13.00K | 14.00K | 55.00K | 88.00K | 96.00K | 150.00K | 434.00K | 446.00K | 319.00K | 316.00K |
EBITDA | -25.14M | -21.48M | -20.64M | -23.99M | -19.56M | -23.81M | -63.23M | -61.66M | -20.99M | -25.96M |
EBITDA Ratio | -10,883.12% | -983.92% | -1,680.94% | -3,048.41% | -352.63% | -207.86% | -7,903.38% | -1,297.24% | -45.43% | -1,745.73% |
Operating Income | -24.99M | -21.70M | -23.28M | -25.74M | -23.70M | -23.97M | -63.74M | -62.22M | -22.28M | -27.57M |
Operating Income Ratio | -10,819.48% | -994.00% | -1,895.93% | -3,270.27% | -427.39% | -209.25% | -7,968.00% | -1,309.11% | -48.23% | -1,854.27% |
Total Other Income/Expenses | -160.00K | 206.00K | 2.75M | 1.66M | 4.05M | -35.00K | -32.00K | 101.00K | -7.63M | 1.28M |
Income Before Tax | -25.15M | -21.49M | -20.53M | -24.08M | -19.65M | -24.01M | -63.78M | -62.12M | -29.91M | -26.29M |
Income Before Tax Ratio | -10,888.74% | -984.56% | -1,672.15% | -3,059.59% | -354.36% | -209.56% | -7,972.00% | -1,306.99% | -64.76% | -1,768.26% |
Income Tax Expense | 4.00K | 10.00K | -124.00K | 13.00K | 14.00K | 16.00K | 19.00K | 435.00K | 975.00K | 1.30M |
Net Income | -25.16M | -21.50M | -20.57M | -24.09M | -19.67M | -23.98M | -63.68M | -62.54M | -29.91M | -26.29M |
Net Income Ratio | -10,890.48% | -985.02% | -1,675.33% | -3,061.25% | -354.62% | -209.31% | -7,960.25% | -1,315.86% | -64.76% | -1,768.26% |
EPS | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
No news found for: ONTXW
Source: https://incomestatements.info
Category: Stock Reports